Skip to main content

Gate — Portfolio, Page 23

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

1,189
Companies
$621.9M
Total invested
$8.3M
Avg. check
54
Industries
Biotechnology 8Health Care 6Medical 5Artificial Intelligence (AI) 4Life Science 4Biopharma 3+48 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 529552 of 1,189
Cork Protocol
January 2026

Cork offers collateralized swaps against any pegged asset.

Decentralized Finance (DeFi) · New York$5.5M Seed
Zelira Hope 1
January 2026

Zelira Hope 1 is owned by Zelira Therapeutics, that focuses on advancing the company's lead cannabinoid-based drug candidate.

$33.0M Series A
Eyam Health
January 2026

Eyam Health concentrates on the investigation and creation of vaccines for defending against infectious diseases.

Biopharma · Surrey$327K Grant
SkyFi®
January 2026

SkyFi® is an earth intelligence platform that provides satellite imagery and analytics to help interpret and analyze planetary data.

Aerospace · Austin$12.7M Series A
AiderX
January 2026

AiderX is a technology startup that creates AI assistants for everyone.

Advertising · Seongnam$6.8M Seed
Wedge
January 2026

Competitive Wedge offers a one-way recorded video interview built for the demands of modern recruiting.

Human Resources · Grand Rapids$1.5M Series Unknown
Replicate Bioscience
January 2026

Replicate Bioscience develops self-replicating RNA therapeutics and vaccines delivering immunity at lower doses across multiple diseases.

Biotechnology · San Diego$7.0M Grant
Just - Evotec Biologics
January 2026

Designing innovative technologies focused on accelerating global access to biotherapeutics.

Biopharma · SeattleGrant
vitrealab
January 2026

vitrealab unlocks Augmented Reality for everyday use, with its proprietary laser matrix photonic integrated circuit.

Vienna$11.0M Series A
STRM.BIO
January 2026

STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy in a more efficient and practical manner.

Biotechnology · Cambridge$8.0M Seed
Bactolife
January 2026

Bactolife is a biotechnology company that develops biological solutions to support gut health.

Biotechnology · Lyngby$35.2M Series B
Terra
January 2026

Terra provides platform to track and remove uncertainties while developing, manufacturing, and shipping products overseas.

Consumer Goods · New YorkSeed
Artifact
January 2026

Artifact provides AI solutions for electrical design, engineering calculations, multi-fidelity system design, and material bill generation.

Artificial Intelligence (AI) · AtlantaSeed
Globavend
December 2025

Globavend e-commerce logistic company that offers end-to-end solution via air freight and on-carriage parcel transportation and delivery.

Freight Service · Perth$934K Post Ipo Equity
ONroute
December 2025

ONroute provides travelers with fuel, food, and beverages.

Customer Service · Mississauga$250.0M Debt Financing
Medistream
December 2025

Medistream operates an integrated platform for oriental medicine.

Health Care · Kangnam$19.0M Series Unknown
ASWEMAKE
December 2025

ASWEMAKE is a shopping app that delivers groceries.

Apps · IncheonSeries C
Sift Biosciences
December 2025

Sift Biosciences is a biotechnology research company that offers cancer therapies.

Biopharma · San Carlos$3.8M Pre-Seed
Payhere
December 2025

Payhere is a fintech company that provides card terminals and online payment gateway services for multiple industries.

Financial Services · Seoul$5.4M Corporate Round
Zoetis
December 2025

Zoetis is an animal health company that advances care for animals and supports their health and wellbeing.

Agriculture · Parsippany$1.8B Post Ipo Debt
Last Energy
December 2025

Last Energy is a nuclear technology company that provides nuclear energy through its modular micro nuclear power plants.

Clean Energy · Washington$100.0M Series C
Attivare Therapeutics
December 2025

Attivare Therapeutics is a biotechnology company that develops small-molecule therapies that modulate immune and inflammatory pathways.

Biotechnology · Natick$6.6M Grant
Wavedash
December 2025

High-quality PC games in the browser

Gaming · San Francisco$3.8M Seed
Pryon
December 2025

Pryon is an enterprise knowledge management platform designed to simplify and accelerate the adoption of artificial intelligence.

Artificial Intelligence (AI) · RaleighConvertible Note

Where Gate invests

Biotechnology8
Health Care6
Medical5
Artificial Intelligence (AI)4
Life Science4
Biopharma3

About Gate's portfolio

How many companies has Gate invested in?

Gate has invested in 1,189 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Gate invest in?

Gate's top investment sectors include Biotechnology, Health Care, Medical, Artificial Intelligence (AI), Life Science. The firm invests across 54 different industry categories.

What is Gate's largest investment?

Among tracked funding rounds, Zoetis received $1.8B in a Post Ipo Debt round. Gate's total known invested capital is $621.9M.

What is the average investment size for Gate?

Gate's average investment size is $8.3M across its portfolio of 1,189 companies.

What are Gate's most recent investments?

Recent Gate portfolio additions include Cork Protocol, Zelira Hope 1, Eyam Health, SkyFi®, AiderX. These companies were founded in 2020 or later.

Reach the founders behind these 1,189 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →